[en] BACKGROUND. Homeobox (HOX)-containing proteins have been identified as regulators controlling the coordinated expression of genes involved in development and differentiation. Recent data also suggest a possible involvement of HOX genes in malignant transformation and/or progression. We have previously shown that HOXC8 expression was selectively turned on in human cervix cancer cells compared with normal keratinocytes, suggesting that HOXC8 may be involved in the process leading to the transformation of cervix keratinocytes [Alami et al.: Biochem Biophys Res Commun 257:738-745,1999]. METHODS. RT-PCR and in situ hybridization experiments were performed to investigate the expression and cell type localization of HOXC8 transcripts in human prostate cancer cell lines and tissues. In situ hybridization was performed with the use of an HOXC8 anti-sense digoxigenin-labeled probe to investigate HOXC8 mRNA expression in 27 prostate cancer tissue specimens. RESULTS. Out of the three human prostate cancer cell lines tested, DU-145 and PC3 but not LNCaP cells expressed detectable amount of HOXC8 transcripts. Results from in situ hybridization experiments demonstrated that HOXC8 gene was expressed mainly in malignant epithelial cells. Furthermore, the staining intensity in epithelial cells was significantly increased in high Gleason score carcinomas (scores 7-9, n = 12; labeling intensity 2 + to 3 +) compared with the one observed in low and intermediate Gleason score tumors (scores 3-6, n = 15; labeling intensity 0 and 1 +) (ANOVA test, P < 0.0001). CONCLUSIONS. Our data showing that HOXC8 overexpression is associated with the loss of tumor differentiation in human prostate cancer suggests that HOXC8 may play a role in the acquisition of the invasive and metastatic phenotype of this malignancy. (C) 2002 Wiley-Liss, Inc.
Disciplines :
Urology & nephrology
Author, co-author :
Waltregny, David ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Labo de recherche sur les métastases
Alami, Younes
Clausse, Nathalie
de Leval, Jean ; Université de Liège - ULiège > Département des sciences cliniques > Urologie
Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire
Language :
English
Title :
Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation
Publication date :
February 2002
Journal title :
Prostate
ISSN :
0270-4137
eISSN :
1097-0045
Publisher :
Wiley Liss, Inc., New York, United States - New York
Graba Y., Aragnol D., Pradel J. (1997) Drosophila Hox complex downstream targets and the function of homeotic genes. Bioessays 19:379-388.
Pradel J., Whit R.A. (1998) From selectors to realizators. Int J Dev Biol 42:417-421.
Gehring W.J., Hiromi Y. (1986) Homeotic genes and homeobox. Ann Rev Genet 20:147-173.
Apiou F., Flagiello D., Cillo C., Malfoy B., Poupon M.F., Dutrillaux B. (1996) Fine mapping of human HOX gene clusters. Cytogenet Cell Genet 73:114-115.
Castelli-Gair J. (1998) Implications of the spatial and temporal regulation of Hox genes on development and evolution. Int J Dev Biol 42:437-444.
Chiba S. (1998) Homeobox genes in normal hematopoiesis and leukemogenesis. Int J Hematol 68:343-353.
Maulbecker C.C., Gruss P. (1993) The oncogenic potential of deregulated homeobox genes. Cell Growth Differ 4:431-441.
Cillo C., Barba P., Freschi G., Bucciarelli G., Magli M.C., Boncinelli E. (1992) HOX gene expression in normal and neoplastic human kidney. Int J Cancer 51:892-897.
De Vita G., Barba P., Odartchenko N., Givel J.C., Freschi G., Bucciarelli G., Magli M.C., Boncinelli E., Cillo C. (1993) Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 29 A:887-893.
Tiberio C., Barba P., Magli M.C., Arvelo F., Le Chevalier T., Poupon M.F., Cillo C. (1994) HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int J Cancer 58:608-615.
Deguchi Y., Yamanaka Y., Theodossiou C., Najfeld V., Kehrl J.H. (1993) High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: Molecular markers of hematopoietic cell immaturity. Leukemia 7:446-451.
Ee H.C., Erler T., Bhathal P.S., Young G.P., James R.J. (1995) Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 147:586-592.
Song K., Wang Y., Sassoon D. (1992) Expression of Hox-7 in myoblasts inhibits terminal differentiation and induces cell transformation. Nature 360:477-481.
Suzuki M., Tanaka M., Iwase T., Naito Y., Sugimura H., Kino I. (1993) Over-expression of HOX-8, the human homologue of the mouse Hox-8 homeobox gene, in human tumors. Biochem Biophys Res Commun 194:187-193.
Landis S.H., Murray T., Bolden S., Wingo P.A. (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6-29.
Hayward S.W., Cunha G.R., Dahiya R. (1996) Normal development and carcinogenesis of the prostate. A unifying hypothesis. Ann NY Acad Sci 784:50-62.
Bhatia-Gaur R., Donjacour A.A., Sciavolino P.J., Kim M., Desai N., Young P., Norton C.R., Gridley T., Cardiff R.D., Cunha G.R., Abate-Shen C., Shen M.M. (1999) Roles for nkx3.1 in prostate development and cancer. Genes Dev 13:966-977.
Vocke C.D., Pozzatti R.O., Bostwick D.G., Florence C.D., Jennings S.B., Strup S.E., Duray P.H., Liotta L.A., Emmert-Buck M.R., Linehan W.M. (1996) Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p 12-21. Cancer Res 56:2411-2416.
Gao A.C., Isaacs J.T. (1996) Expression of homeobox gene-GBX2 in human prostatic cancer cells. Prostate 29:395-398.
Gao A.C., Lou W., Isaacs J.T. (1998) Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. Cancer Res 58:1391-1394.
Sreenath T., Orosz A., Fujita K., Bieberich C.J. (1999) Androgen-independent expression of HOXB-13 in the mouse prostate. Prostate 41:203-207.
Alami Y., Castronovo V., Belotti D., Flagiello D., Clausse N. (1999) HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochem Biophys Res Commun 257:738-745.
Wheeler T.M., Lebovitz R.M. (1994) Fresh tissue harvest for research from prostatectomy specimens. Prostate 25:274-279.
Waltregny D., Bellahcene A., Van Riet I., Fisher L.W., Young M., Fernandez P., Dewe W., De Level J., Castronovo V. (1998) Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 90:1000-1008.
Van den Brule F.A., Waltregny D., Castronovo V. (2001) Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 193:80-87.
Gleason D.F., Mellinger G.T. (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58-64.
Chirgwin J.M., Prazybyla A.E., MacDonald R.J., Rutter W.J. (1979) Isolation of biologically ative ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
Simeone A., Acampora D., Nigro V., Faiella A., D'Esposito M., Stornaiuolo A., Mavilio F., Boncinelli E. (1991) Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells. Mech Dev 33:215-227.
Visakorpi T., Kallioniemi A.H., Syvanen A.C., Hyytinen E.R., Karhu R., Tammela T., Isola J.J., Kallioniemi O.P. (1995) Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
Sattler H.P., Rohde V., Bonkhoff H., Zwergel T., Wullich B. (1999) Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer. Prostate 39:79-86.
Yueh Y.G., Gardner D.P., Kappen C. (1998) Evidence for regulation of cartilage differentiation by the homeobox gene Hoxc-8. Proc Natl Acad Sci U S A 95:9956-9961.
Cussenot O. (1997) Growth factors and prostatic tumors. Ann Endocrinol (Paris) 58:370-380.
Care A., Silvani A., Meccia E., Mattia G., Soppaciaro A., Parmiani G., Peschle C., Colombo M. (1996) HOX B7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol 16:4842-4851.